Myasthenia gravis, malignant thymoma, multiple schwannomas and monoclonal IgA gammopathy coexisted in a 54-year-old Japanese man. Serum acetylcholine receptor antibody activity was located in the IgG fraction, but not in the paraprotein peak. It was speculated that all these disorders might fall under the spectrum of the diseases associated with thymic abnormality or that some growth factors might induce neoplasms and activation of B cell clones of autoantibodies (including acetylcholine receptor antibody) in this case.
of multiple schwannomas and monoclonal IgA gammopathy as observed in this patient, however, is not typical of MG. To our knowledge, this is the first patient reported with this unusual combination of rare diseases. The incidence of extrathymic neoplasms is higher in MG with thymoma than the expected in a control group. Papatestas et al reported that the incidence of primary brain and CNS tumors in patients with MG having extrathymic neoplasms was 5.3% and there was a case report of MGwith thymoma and ganglioneuroma. On the other hand, it is known that neurofibromatosis is one of conditions associated with thymoma. One possible explanation for the relationship between thymoma and neoplasm of nervous system, might be that both tumors have a common origin in the neural crest, since embryogenetically the thymic mesenchyme is known to be predominantly derived from the neural crest. According to the conventional criteria, the present case is compatible with the benign monoclonal IgA gammopathy. Several cases of thymoma with monoclonal gammopathies have been reported.7'8^ Furthermore, four cases have been reported with apparent association of M-component and MG; one of the four had multiple myeloma ' and the others had benign monoclonal gammopathies (IgG9' 10) and IgMll}).
On the assumption that the M-component (IgA) in this patient contained AChR antibody activity, we measured the antibody titre with rabbit anti-human IgA. But the antibody activity was not located in the IgA peak, but in the IgG group. Somer et al also reported a negative result in a case of MG with monoclonal IgG gammopathy. The radiation therapy on the thymus is known as one of the treatments of MG. This treatment is useful for invasive thymoma. In this case, the symptoms of MG appeared after radiation therapy. As development of MG following thymectomy has been reported,1 similar effect might work in this case. Although lack of enough definite insight regarding control mechanisms for oncogenesis and immunological regulations makes any attempt to explain multiple disorders (MG, multiple schwan- 
